GLP-1 Agonists and Kidney Health: What You Need to Know

**Title: The Role of GLP-1 Agonists in Kidney Health: A Comprehensive Overview** **Date: October 5, 2023**…

GLP-1 and Lipid Metabolism: A Comprehensive Overview

**Title: The Emerging Role of GLP-1 in Lipid Metabolism: A Comprehensive Overview** **Glucagon-like peptide-1 (GLP-1) is…

Azurity acquires Covis Pharma from existing investors

Azurity Pharmaceuticals has acquired Covis Group from existing investors, making the latter a wholly owned subsidiary.

The cost of insurance cuts | Morning Newsletter – The Philadelphia Inquirer

The cost of insurance cuts | Morning Newsletter  The Philadelphia Inquirer

Kansas, we’re more obese than the national average. These new medications can help | Opinion – Kansas City Star

Kansas, we’re more obese than the national average. These new medications can help | Opinion  Kansas City…

Anti-Obesity Drugs Market Industry Trends, Sales Forecast, – GlobeNewswire

Anti-Obesity Drugs Market Industry Trends, Sales Forecast,  GlobeNewswire

Anti-Obesity Drugs Market Industry Trends, Sales Forecast, – GlobeNewswire

Anti-Obesity Drugs Market Industry Trends, Sales Forecast,  GlobeNewswire

Comparing GLP-1 Receptor Agonists: Which is Best?

**Title: Understanding GLP-1 Receptor Agonists: A Comprehensive Overview** **GLP-1 receptor agonists are a class of medications…

The weight loss drug shortage is over — and some patients are ‘panicking’ – Quartz

The weight loss drug shortage is over — and some patients are ‘panicking’  Quartz

Some Philly patients worry about affording their medications as insurers cut coverage for weight-loss drugs – The Philadelphia Inquirer

Some Philly patients worry about affording their medications as insurers cut coverage for weight-loss drugs  The Philadelphia…